Apoptos' Series A Round

Apoptos raised a round of funding on May 22, 2008.

Apoptos, Inc. is focused on discovering and developing effective, targeted small-molecule anticancer drugs that activate apoptosis (programmed cell death).…

Articles about Apoptos' Series A Round: